We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Doubles Down on Injectables With $1.6 Billion Buy of India’s Agila
Mylan Doubles Down on Injectables With $1.6 Billion Buy of India’s Agila
February 28, 2013
Mylan will acquire India’s Agila Specialties for $1.6 billion in a bid to blossom into a generic injectables “powerhouse” and bring stability to a pharma sector beset by shortages.